X

You deserve more, Find tenders and business leads on the GO

Download Online Tenders iOS app Download Online Tenders Android app
Online Tenders
  • VIEW TENDERS
  • PRICING
    • Home
    • Browse Tenders
    • Pricing
    • How it Works
    • Tender Resources
    • FAQ
    • Signup
    • Login
    • Contact Us
  • LOGIN
  • SIGN UP
Resources How to Tender Tender Articles Tender Sectors Tender News

Aspen Pharmacare readying to make Johnson & Johnson Covid vaccine

Global healthcare group Johnson & Johnson (J&J) will decide if any of the 230 million doses of Covid-19 vaccine scheduled to be produced at Aspen Pharmacare’s Port Elizabeth factory will be sold in the South African market, Aspen senior executive, strategic trade, Stavros Nicolaou said Tuesday.

SA needs to vaccinate around 40 million South Africans or 65-70 percent of its population in months to achieve herd immunity and contain the public health emergency, and to get traction behind economic recovery.

Aspen will contract manufacture to produce the J&J vaccine in Port Elizabeth following the signing of a technology transfer agreement between the two companies, he said in an interview with Business Report.

On Sunday evening health minister Zweli Mkhize said the government aimed to have vaccines available, initially for healthcare workers, by February, but the government was still in talks with pharmaceutical companies and no deals had been signed as yet.

There has however been growing criticism, such as from trade unions, of the slow response from the government in obtaining vaccines from international companies such as Pfizer that have developed the drug - many other countries have started rolling out mass immunisation programmes.

J&J’s vaccine, in Phase 3 clinical trials. would be the third vaccine seeking authorization from the US’s Food and Drug Administration expected later this month, if the Phase 3 clinical trials were successful, and the vaccine would also subsequently have to be approved by the South African Health Products Regulatory Authority (SAHPRA), Nicolaou said.

The J&J vaccine was expected to become available globally in the second quarter. J&J’s vaccine was developed by Janssen Pharmaceuticals, a Belgium based division of J&J. Nicolaou said expert opinion indicated the J&J vaccine, and the AstraZeneca/Oxford University vaccine being rolled out in the UK, appeared the two best suited to South African conditions.

These two vaccines would not require the stringent refrigerated transport and storage requirements that are required by the two most widely available and FDA approved vaccines in the world at present, the Pfizer and Moderna vaccines, while the J&J vaccine would require only one dose. The Pfizer and the Modern vaccines have already been submitted to the SAHPRA for approval.

Nicolaou said 6 million South Africans were likely to be vaccinated from the Covax initiative, a pooled arrangement to procure some 200 billion vaccines from a range of manufacturers to provide to up to 20 percent of the populations of poorer countries. At present, the Covax initiative is the only firm commitment that South Africa has to access to a vaccine, but bilateral discussions were underway with manufacturers.

Nicolaou said a further 34 million South Africans would need to be vaccinated for herd immunity to be achieved, and the private and public sector was currently working with medical schemes to provide a funding mechanism for some of the remaining populations.

Source: www.iol.co.za
BACK TO NEWS

Latest News

  • How bargaining councils are fighting the construction mafia
  • Investigations into R3.2 billion tender lead to executives facing charges
  • Msunduzi Municipality fleet boss jailed for 10 years for tender bribes
  • The Strand seawall project
  • Transport Department races to clear 733,000 driving licence backlog
  • Serious procurement irregularities in Lesseyton Sports Facility
  • KZN introduces innovative e-procurement system to combat corruption
  • City of Tshwane saves millions by insourcing construction services
  • eThekwini Municipality in clash with company over parking meters contract
  • Concerns over government spending on outdated driving licence printing machine
  • ONLINE TENDERS © 2024
  • Terms
  • Privacy
  • Resources
  • Contact Us
By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies. All trademarks are properties of their respective owners. 2007-2025 © Online Tenders CC. All rights reserved.
By using this site you agree to OnlineTenders use of cookies to give you a personalised experience. Please read the cookie policy for more information.
Accept